STEVEN KUSSICK M.D., PH.D.
NPI 1790889210
Specialist in Seattle, WA

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Chromosome analysis for genetic defects, analyze 20-25 cells

Chromosome analysis is a test that evaluates your cells to check for genetic defects. In this procedure, 20-25 cells are examined under a microscope to identify any abnormalities. This information can help in diagnosing certain genetic conditions and guide treatment plans.

This service was performed 25 times for 25 patients

Flow cytometry technique for dna or cell analysis, 16 or more markers

Flow cytometry is a method used to measure and analyze cells. It uses a beam of light to detect up to 16 or more markers on cells, helping to identify their type, function, or abnormalities. This technique aids in diagnosing various health conditions.

This service was performed 303 times for 280 patients

Flow cytometry technique for dna or cell analysis, 9 to 15 markers

Flow cytometry is a technique used to measure physical and chemical characteristics of cells or particles. It can analyze multiple markers (9 to 15) on a cell, helping to identify its type and function. This process can also examine DNA within cells for any abnormalities.

This service was performed 74 times for 73 patients

Flow cytometry technique for dna or cell analysis, each additional marker

Flow cytometry is a technique that helps analyze the physical and chemical characteristics of cells or particles. When an additional marker is used, it aids in identifying specific cell types or stages of disease. This helps in precise diagnosis and treatment planning.

This service was performed 830 times for 37 patients

Flow cytometry technique for dna or cell analysis, first marker

Flow cytometry is a technique used to examine microscopic particles, like cells or DNA. It employs a beam of light to detect and measure physical and chemical characteristics of these particles. The 'first marker' refers to a specific characteristic or feature used to identify a particular cell or particle.

This service was performed 38 times for 37 patients

Gene analysis (calreticulin), common variants

Gene analysis of calreticulin, common variants, is a test that looks at specific genes to identify changes that may cause certain health issues. It helps in understanding your genetic makeup and potential health risks. It's a simple procedure involving a blood or saliva sample.

This service was performed 14 times for 14 patients

Gene analysis (epidermal growth factor receptor), common variants

Gene analysis of the epidermal growth factor receptor (EGFR) identifies common variants in this particular gene. This test helps in understanding your body's response to certain medications. It aids in personalized treatment planning, ensuring the most effective care.

This service was performed 62 times for 62 patients

Gene analysis (janus kinase 2) variant

Gene analysis (Janus Kinase 2 variant) is a test that examines your DNA to identify any changes in the JAK2 gene. This gene is crucial for blood cell production. If it's mutated, it can lead to various blood disorders. The test helps in diagnosing these conditions.

This service was performed 44 times for 44 patients

Gene analysis (kirsten rat sarcoma viral oncogene homolog), additional variants

Gene analysis of the Kirsten rat sarcoma viral oncogene homolog (KRAS) checks for extra variations in the KRAS gene. These variations may impact how your body responds to certain treatments. It's a non-invasive test, usually done on a blood or tissue sample.

This service was performed 31 times for 31 patients

Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants

Gene analysis for the MPL proto-oncogene, thrombopoietin receptor, is a test that looks for common genetic variants. This helps in understanding certain health conditions related to blood cell production. It's a non-invasive procedure, involving a simple blood draw.

This service was performed 11 times for 11 patients

Gene analysis (myeloid differentiation primary response 88) for p.leu265pro variant

Gene analysis for the p.Leu265Pro variant involves studying the MYD88 gene, which plays a crucial role in immune response. This test helps identify changes in this gene that could potentially cause health issues. It's a non-invasive procedure, done through a blood sample.

This service was performed 63 times for 61 patients

Gene analysis (t cell antigen receptor beta) amplification methodology

Gene analysis of T cell antigen receptor beta, using amplification methodology, is a process where the specific genes in your T cells are examined. This helps determine your body's immune response to diseases. It's a non-invasive procedure that aids in understanding your health better.

This service was performed 23 times for 22 patients

Gene analysis (v-ki-ras2 kirsten rat sarcoma viral oncogene) variants in codons 12 and 13

Gene analysis for v-ki-ras2 kirsten rat sarcoma viral oncogene variants in codons 12 and 13 is a test to identify specific changes in your genes. These changes could potentially indicate a higher risk for certain types of cancer.

This service was performed 30 times for 29 patients

Gene analysis (v-raf murine sarcoma viral oncogene homolog b1)

Gene analysis of v-raf murine sarcoma viral oncogene homolog b1 (BRAF) is a test that examines your DNA to identify changes or mutations in the BRAF gene. This information can help in diagnosing and treating certain diseases, including some types of cancer.

This service was performed 70 times for 70 patients

Gene rearrangement analysis (immunoglobulin heavy chain locus) to detect abnormal clonal population amplified methodology

Gene rearrangement analysis is a test that checks for abnormal cells in your body. It focuses on a specific part of your DNA, the immunoglobulin heavy chain locus. The test amplifies this area to detect if abnormal, or 'clonal', cells are present.

This service was performed 52 times for 51 patients

Gene rearrangement analysis (immunoglobulin kappa light chain locus) to detect abnormal clonal population

Gene rearrangement analysis is a lab test performed on your cells. It studies the immunoglobulin kappa light chain locus, which is part of your immune system. The aim is to find any abnormal clones, which could indicate a health issue.

This service was performed 25 times for 24 patients

Gene rearrangement analysis detection abnormal clonal population (t cell antigen receptor gamma)

Gene rearrangement analysis is a test that identifies abnormal T cells, which may indicate certain health conditions. It examines the T cell antigen receptor gamma, a key part of the immune system. It's like a detective looking for unusual patterns in your body's defenders.

This service was performed 74 times for 71 patients

Genetic sequencing localization, initial procedure

Genetic sequencing localization is a process to identify where specific genes are located in your DNA. During the initial procedure, a sample of your cells is collected, usually through a simple swab or blood test. This data is then analyzed to pinpoint the location of certain genes. This can help understand your genetic makeup and potential health risks.

This service was performed 18 times for 17 patients

Microscopic genetic analysis of tissue, computer-assisted technology, each additional procedure

Microscopic genetic analysis of tissue is a process where a small piece of tissue is examined under a microscope to identify any genetic abnormalities. This is typically done with the aid of computer technology for precision. Each additional procedure refers to repeated or extra tests conducted to gather more data or confirm results.

This service was performed 43 times for 36 patients

Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure

This procedure involves the detailed study of your tissue's genetic makeup using a microscope and computer-assisted technology. It's the first step in a series of tests to understand your body better and provide appropriate care.

This service was performed 40 times for 40 patients

Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure

This procedure involves analyzing tissue at a genetic level using a microscope and advanced computer technology. The initial process involves the collection and preparation of tissue samples. Each multiplex procedure refers to the simultaneous testing of multiple genetic markers to identify abnormalities.

This service was performed 260 times for 99 patients

Microscopic genetic analysis of tumor, manual

Microscopic genetic analysis of a tumor involves examining your tumor's genes under a microscope. This helps identify specific genetic changes in the tumor cells. This information can aid in diagnosing, predicting disease progression, and determining the most effective treatment options.

This service was performed 237 times for 107 patients

Molecular pathology procedure; physician interpretation and report

A molecular pathology procedure involves analyzing your body's cells at a molecular level to identify any abnormalities. This can help detect diseases early. A physician will interpret the results and provide a detailed report, explaining the findings clearly.

This service was performed 119 times for 71 patients

Pathology examination of tissue using a microscope, intermediate complexity

A pathology examination of tissue with intermediate complexity involves studying a small sample of your body tissue under a microscope. This helps in identifying any abnormal cells or signs of disease. It's a detailed process requiring expert analysis to ensure accurate results.

This service was performed 53 times for 37 patients

Special stained specimen slides to examine tissue including interpretation and report

Special stained specimen slides are used to examine tissue samples. This involves applying special dyes to the tissue, which helps to highlight certain features under a microscope. The findings are then interpreted and a report is provided. This can aid in diagnosing various health conditions.

This service was performed 19 times for 14 patients

Special stained specimen slides to examine tissue, each additional procedure

Special stained specimen slides are used to analyze tissue in detail. In this process, extra procedures may be needed for a more thorough examination. These involve applying special stains to the tissue on slides, enhancing specific elements for closer study.

This service was performed 611 times for 89 patients

Special stained specimen slides to examine tissue, initial procedure

This procedure involves the use of specially stained slides to examine tissue samples. The initial process involves obtaining a small tissue sample from your body. This sample is then placed on a slide and stained with special dyes to highlight different structures and elements. The stained slide is then examined under a microscope to help diagnose any potential health issues.

This service was performed 152 times for 145 patients

Surgical pathology consultation and report on referred material requiring preparation of slides

A surgical pathology consultation involves the examination of tissue removed during surgery. The tissue is processed and slides are prepared for detailed study under a microscope. The findings are then compiled into a report to help guide your treatment plan.

This service was performed 86 times for 84 patients

Tissue culture for tumor disorders of bone marrow and blood cells

Tissue culture for tumor disorders of bone marrow and blood cells is a lab process where your cells are grown in a controlled environment. The aim is to detect and study abnormal cells, such as cancer, in your bone marrow or blood. This helps in planning effective treatment.

This service was performed 26 times for 26 patients

Translocation analysis (bcr/abl1) major breakpoint

Translocation analysis (bcr/abl1) major breakpoint is a test that checks for a specific gene rearrangement in your cells. This rearrangement is often seen in certain types of leukemia. The test helps doctors diagnose and monitor treatment for these conditions.

This service was performed 83 times for 60 patients

Translocation analysis (bcr/abl1) minor breakpoint

Translocation analysis (bcr/abl1) minor breakpoint is a genetic test that identifies specific changes in chromosomes. It's used to diagnose certain types of blood cancers. The test detects rearrangements of genetic material, aiding in the treatment plan.

This service was performed 82 times for 61 patients

Overall MIPS Quality Performance

The provider participated in CMS Quality Payment Program under the Merit-based Incentive Payment System (MIPS) and has an overall final score of 0, based on four performance areas: quality, improvement activities, promoting interoperability, and cost. The purpose of this information is to help people with Medicare make informed decisions and incentivize doctors and clinicians to maximize performance.

The Merit-based Incentive Payment System (MIPS) is a way providers could use to participate in CMS Quality Payment Program (QPP). The MIPS program affects clinician reimbursement for Part B covered professional services and also rewards them for improving the quality of patient care and outcomes.

• Final Score: 0 out of 100

  The MIPS program evaluates providers across multiple categories with a specific weight for each category resulting a in a MIPS final score that ranges from 0 to 100 points. The MIPS Final Score determines whether providers receive a negative, neutral or positive MIPS payment adjustment.
  
  

• Quality Score: 0

  The Quality category assesses providers performance on clinical practices and patient outcomes under the traditional MIPS program. The quality measures help identify the quality of healthcare processes, outcomes, and patient experiences. The Quality measure category compromises 40% providers final MPIS scores.
  
  There are six collection types for MIPS quality measures: Electronic Clinical Quality Measures (eCQMs), MIPS Clinical Quality Measures (CQMs), Qualified Clinical Data Registry (QCDR) Measures, Medicare Part B claims measures, CMS Web Interface measures and The Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS Survey.
  
  

• Promoting Interoperability Score: N/A

  The Interoperability category measures the providers ability to use technology to exchange and make use of healthcare information in a way that is less burdensome and improves outcomes. The Interoperability measure category compromises 25% providers final MPIS scores.
  
  The MIPS Interoperability measure focuses on the use of certified electronic health record technology (CEHRT) to improve patient access health information, the exchange of information between clinicians and pharmacies and the systematic collection, analysis, and interpretation of healthcare data.

• Improvement Activities Score: 0

  The Improvement Activities performance category evaluates the providers participation in clinical activities that support the improvement of clinical practice, care delivery, and outcomes. Providers have the option to choose 2 to 4 activities from an inventory of over 100 improvement activities. Providers typically choose the activities that best fit their needs. The improvement activities measure category compromises 15% providers final MPIS scores.
  
  The Improvement measures aim to better patient engagement, patient safety and other areas of patient care. The Improvement Activities category compromises 15% of providers final MPIS scores.

• Cost Score: N/A

  The Cost performance category asses the amount and types of services provided and how clinicians coordinate care and seek improvement of health outcomes by ensuring patients receive the appropriate services.
  
  Although providers don't determine the price of healthcare services they are important in delivering high-quality care at a reasonable cost. The Cost measures category compromises 20% of providers final MPIS scores.

• Cost Score: N/A

  The Cost performance category asses the amount and types of services provided and how clinicians coordinate care and seek improvement of health outcomes by ensuring patients receive the appropriate services.
  
  Although providers don't determine the price of healthcare services they are important in delivering high-quality care at a reasonable cost. The Cost measures category compromises 20% of providers final MPIS scores.

Reviews for STEVEN KUSSICK M.D., PH.D.

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

Frequently Asked Questions